Project Title

PRION-LIKE GENOMIC INSTABILITY, CAG EXPANSION, TRAUMA-EPIGENOMICS, AND NEURODEVELOPMENTAL INTELLIGENCE METRICS

Project Codename: PROJECT NEUROFOLD-CAG

Framework Code: SCF-AMC-NFCAG-0001

Disease Domain: Huntington’s disease, polyglutamine disorders, prion-like proteinopathies, neurodevelopmental trauma biology

Primary Gene: HTT

Core Molecular Event: CAG repeat expansion → polyglutamine expansion → protein misfolding → neurodegenerative progression

Important correction: Huntington’s disease is not a classical prion disease, but it is a prion-like proteinopathy because mutant huntingtin can misfold, aggregate, seed, and propagate pathology between cells. Classical prion diseases are caused by misfolded prion protein, PrP, and are rare fatal TSEs.

I. Research Mission

To determine whether CAG repeat burden, somatic repeat expansion, DNA repair injury, protein misfolding load, maternal trauma-epigenomic imprinting, and neurobehavioral regulation can be integrated into a quantified SCF model for:

1. Neurodevelopmental vulnerability
2. Intelligence-related biological capacity
3. Neurodegenerative activation risk
4. Symptom flare prediction
5. Disease progression modeling

II. Core Research Questions and SCF Hypotheses

PHASE 0 — DISEASE INTELLIGENCE & POSITIONING

Disease Definition

Huntington’s disease is an autosomal dominant neurodegenerative disorder caused by CAG expansion in the HTT gene, producing mutant huntingtin with an expanded polyglutamine tract.

Disease Classification

Mandatory Deliverables

1. Disease Intelligence Report
2. HD / PolyQ / Prion-Like Proteinopathy Positioning Dossier
3. Knowledge Gap Assessment
4. Neurodevelopmental Risk Matrix
5. SCF Research Charter

PHASE 1 — DISEASE ORIGIN DISCOVERY

Etiological Origin

Key Scientific Premise

Recent work indicates that HTT CAG repeats can expand somatically from inherited pathogenic ranges into much larger repeat lengths in vulnerable striatal neurons, supporting a life-course model rather than a strictly embryonic-only model.

PHASE 2 — SCF FAULT ARCHITECTURE

PHASE 3 — MULTI-OMICS RECONSTRUCTION

Core Genes for Study

PHASE 4 — PATHOGENESIS & PROGRESSION MODEL

SCF Progression Logic

HTT CAG Expansion

→ Mutant Huntingtin PolyQ Elongation

→ Protein Misfolding

→ Proteostasis Burden

→ Somatic Repeat Expansion

→ Striatal Neuron Vulnerability

→ Cognitive / Behavioral / Motor Symptoms

→ Neurodegenerative Progression

PHASE 5 — MATERNAL TRAUMA, PRECONCEPTION, AND PREGNANCY MODEL

SCF Trauma-Epigenomic Hypothesis

Maternal trauma before conception and during pregnancy may influence offspring neurodevelopment through:

This does not mean trauma causes HTT expansion, but trauma biology may shape resilience, symptom expression, psychiatric burden, and developmental vulnerability.

PHASE 6 — DISEASE MODELING & SIMULATION

Proposed SCF Quantified Metrics

PHASE 7 — BIOMARKER DISCOVERY

Biomarker Classes

PHASE 8 — THERAPEUTIC VULNERABILITY DISCOVERY

DNA repair genes such as MSH3 and PMS1 are being investigated as therapeutic targets for reducing somatic CAG expansion.

PHASE 9 — ADVANCED MEDICINE TRANSLATION

SCF-PCR Therapeutic Architecture

PHASE 10 — MASTER DISEASE INTELLIGENCE SYNTHESIS

Final Research Deliverables

1. SCF Encyclopedia Entry: HTT-CAG Prion-Like Proteinopathy
2. Master Disease Intelligence Dossier
3. CAG Expansion and DNA Repair Atlas
4. Maternal Trauma-Epigenomic Neurodevelopment Report
5. SCF Neurofunctional Capacity Metric Framework
6. Behavioral Flare and Disease Progression Model
7. Therapeutic Opportunity Blueprint

Direct Answers to the Five Questions

1. No, CAG repeats are not a direct intelligence metric. A valid metric would need to combine genetics, neurodevelopment, connectomics, cognition, behavior, environment, trauma load, and adaptive function.
2. Inherited repeat length is set at conception, but somatic expansion can occur during life. This is now a major model in Huntington’s disease progression.
3. Other measurable genes include BDNF, COMT, DRD2, GRIN2A/B, NR3C1, FKBP5, MECP2, SHANK3, CNTNAP2, APOE, TREM2, MSH3, FAN1, PMS1, and PMS2. These should be interpreted as network markers, not deterministic intelligence genes.
4. Maternal trauma may influence neurodevelopment through epigenetic, endocrine, inflammatory, placental, and stress-axis pathways. It may increase vulnerability to psychiatric, cognitive, behavioral, developmental, trauma-related, and neurodegenerative phenotypes, but it should not be framed as a sole cause.
5. Moral cognition, conscious behavior, emotional intelligence, and trauma loops may influence symptom burden through stress physiology, sleep, inflammation, impulsivity, adherence, and autonomic regulation. They may modulate flare severity and progression burden, but they do not create the HTT mutation.

MASTER REGISTRY INDEX

SCF-AMC-NFCAG-0001 — PROJECT NEUROFOLD-CAG

SCF-DMRD-MASTER-0001 — SCF Advanced Disease Modeling & Discovery

SCF-ENC-PRG-0001 — Prionogenesis

SCF-ENC-TSE-0001 — Transmissible Spongiform Encephalopathies

SCF-ENC-CAG-0001 — CAG Repeat Expansion Disorders

SCF-PATH-UT-0001 — SCF Pathophysiology Protocol

SCF-DBI-0001 — Decentralized Biological Intelligence Framework

SCF-CMF-0001 — Conscience Mind Framework

SCF-AQB-0001 — Atomic Quantum-Biology Framework